Cardozo, A, Lleida, R, Szafranska, J, Piñol, D, Serdà, P, Martin-Cullell, B, Manrique, A, López-Bravo, D, Mateo, FJ. From the Rare to the Extraordinary Pancreatic Serous Cystadenocarcinoma With Hepatic and Bone Dissemination: A Letter to the Editor. PANCREAS. 2024; 53(9)DOI:10.1097/MPA.0000000000002362. PMID:39250559. IF:1.700(Q3/8D).

Sullivan, I, Aguado, C, Baroni, M, Teixeira, S, Bertran, J, Giménez, A, Aldeguer, E, Román, R, Reguart, N, López, L, Cavagna, R, Marín, E, García, B, Rodriguez, S, Rosell, R, Ferro, L, Chae, Y, Reis, R, Molina, MA. RET overexpression in absence of fusions or mutations associates with sensitivity to RET TKIs in lung cancer. EUROPEAN JOURNAL OF CANCER. 2024; 211DOI:10.1016/j.ejca.2024.114800. PMID:. IF:7.100(Q1/2D).

Esquirol, A, Pascual, MJ, Montoro, J, Piñana, JL, Ferrà, C, Herruzo, B, Garcia-Cadenas, I, Balaguer, A, Perez, A, Huguet, M, Redondo, S, Villalba, M, Hernandez-Boluda, JC, Chorao, P, Hernani, R, Sanz, J, Solano, C, Sierra, J, Martino, R. Comparison of Three Graft-versus-Host Disease Prophylaxis Strategies after T Cell-Replete Haploidentical Hematopoietic Transplantation: Tacrolimus versus Calcineurin Inhibitors plus Mycophenolate Mofetil versus Sirolimus plus Mycophenolate Mofetil. Transplantation And Cellular Therapy. 2024; 30(10)DOI:10.1016/j.jtct.2024.07.027. PMID:39116938. IF:4.400(Q1/1D).

Spyridonidis, A, Labopin, M, Savani, B, Kulagin, A, Blaise, D, Versluis, J, Sica, S, Raiola, AM, Vydra, J, Choi, G, Rovira, M, Kwon, M, Sanz, J, It la-Remes, M, Borne, PV, Martino, R, Koc, Y, Brissot, E, Nagler, A, Mohty, M, Ciceri, F. THE IMPACT OF INDIVIDUAL COMORBIDITIES ON NRM RISK FOLLOWING PTCY BASED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: AN ALWP EBMT STUDY. BONE MARROW TRANSPLANTATION. 2024; 59DOI:. PMID:. IF:5.200(Q1/1D).